Aug 30, 2024, 07:34 by

Indica Labs and Paige have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP®.

Aug 29, 2024, 01:00 by User Not Found

Clinical Research News | Third Arc Bio plan to advance through clinical studies to address significant unmet needs in oncology and autoimmunity; Halda Therapeutics are looking to advance two RIPTAC candidates into clinical trials for patients with prostate cancer and breast cancer; Outpace Bio will advance multiple programmed T cell product candidates to early clinical proof-of-concept for the treatment of solid tumors; and more.

Aug 28, 2024, 01:00 by User Not Found

Clinical Research News | myTomorrows and Pancreatic Cancer Europe have announced a new partnership to equip patients, caregivers, and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them; the National Institutes of Health has awarded the Ohio State University a $4.38 million grant to support newly trained clinician-scientists for careers in medical research; and more.

Aug 27, 2024, 01:00 by User Not Found

Clinical Research News | On Monday last week, Walgreens and the Biomedical Advanced Research and Development Authority (BARDA), a part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), announced a strategic partnership to further the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program.

Aug 23, 2024, 01:00 by User Not Found

Clinical Research News | n a post-pandemic environment, we know the emergence of another viral risk is inevitable. As such, the broader healthcare ecosystem has evaluated insights from drug development efforts in recent years to develop a shared focus on improving vaccine readiness and equitable access by populations of low-to-middle income countries, or “LMICs.”

Aug 21, 2024, 08:04 by

Abselion has announced the collaboration of leading biotechnology companies and research organizations in UK and Canada to develop next-generation cell platform for viral vector production.

Aug 20, 2024, 08:20 by

Aug 20, 2024, 01:00 by User Not Found

Clinical Research News | Last week, the National Institutes of Health (NIH) has launched the Native Collective Research Effort to Enhance Wellness (N CREW) Program, an effort support Native American communities to lead public health research to address overdose, substance use, and pain, including related factors such as mental health and wellness. The planned program funding totals approximately $268 million over seven years.

Aug 16, 2024, 08:01 by

Phastar named in 2024 Environment 100 List Phastar continues to lead the CRO industry in corporate responsibility as CEO Graham Clark is named in list of trailblazers, innovators and visionaries.

Aug 15, 2024, 01:00 by User Not Found

Clinical Research News | The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling more than $165 million for new patient-centered comparative clinical effectiveness research (CER), as well as research to improve methods and strengthen the science of engagement in patient-centered CER.

Aug 14, 2024, 07:34 by

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, is proud to announce the launch of its AIM-MASH product on the AISightⓇ1 Image Management System (IMS). This product provides advanced AI-based measurement (AIM) to support the analysis of MASH Clinical Research Network (CRN) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Activity Score (MAS) component grades and fibrosis staging. The launch of AIM-MASH on AISight aims to increase the reproducibility and scalability of pathologists' assessments and management of MASH cases, which are projected to reach 27 million in the US alone by 2030.

Aug 14, 2024, 07:34 by

eClinical Solutions announced newly released product enhancements and AI-enabled functionality within the elluminate Clinical Data Cloud ®. Recent platform updates offer clinical teams increased oversight and efficiency amid trial complexity and advance the AI technology footprint of life sciences organizations.

Aug 14, 2024, 01:00 by User Not Found

Clinical Research News | Cancer cells are “not like superheroes that have no vulnerabilities.” Most current therapies try to block the signaling to prevent cancer’s uncontrolled division, but inevitably tumor cells resist the blockage and become far less responsive to subsequent therapy.

Aug 13, 2024, 01:00 by User Not Found

Clinical Research News | In today's data-driven world, clinical trials rely heavily on effective data management to ensure the accuracy and integrity of research findings. Improved data management outcomes ultimately benefit the primary beneficiary—the patient.

Aug 9, 2024, 06:55 by

Aug 9, 2024, 06:54 by

ECI (Enhanced Compliance Inc.), a leading provider of regulatory, quality and engineering services and solutions for the life sciences industries, today announced the appointment of Brijesh Patel as the company’s new Chief Executive Officer (CEO), replacing Hoyt Randall Smith, who has announced his retirement.

Aug 8, 2024, 05:00 by User Not Found

Clinical Research News | A federal mandate that all state Medicaid programs cover the routine costs of participation in clinical trials could have a “meaningful impact” on equity in study participation. The focus should now be on ensuring states collaborate with frontline clinicians to ensure they are aware of the latest Medicaid policy change, and that those who “disproportionately treat patients from minoritized communities are plugged into relevant trial networks and able to refer patients to [applicable] trials.”

Aug 8, 2024, 04:49 by

Infinity Bio has been chosen by The Environmental Determinants of Diabetes in the Young (TEDDY) study to provide antibody reactome services. This collaboration aims to advance the understanding of environmental factors contributing to type 1 diabetes. Infinity Bio’s innovative technology will be used to analyze antibody responses, offering critical insights for diabetes research. This partnership signifies a major step forward in biomedical research, with the potential to enhance diabetes prevention and treatment strategies.

Aug 6, 2024, 07:39 by

Aug 6, 2024, 07:39 by

Rho, a full-service contract research organization (CRO), has appointed leading neurologist Dr. Andrew Feigin as its new chief medical officer (CMO). In this pivotal global role, Dr. Feigin will provide strategic medical and operational expertise across multiple therapeutic areas, ensuring the integrity and safety of Rho’s clinical trials. Dr. Feigin's career is marked by groundbreaking contributions to neurology and clinical research. He served as the site principal investigator on more than 30 clinical trials, notably spearheading the first phase 1 clinical trial using gene therapy for Parkinson's disease. His prolific contributions to the field include over 150 peer-reviewed articles and numerous advisory board positions.